Search
Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.
News
08 May 2024
On 8 April 2024, the Dutch Minister of Medical Care sent a letter to Dutch Parliament (in Dutch: “Tweede Kamer”) regarding interactions between life sciences companies and...
News
06 May 2024
The U.S. Food and Drug Administration (FDA) has finalized its historic — and notoriously controversial — rule to explicitly assert the agency’s authority to regulate...
News
06 May 2024
On May 3, 2024, the Centers for Medicare & Medicaid Services (CMS) issued draft guidance for initial price applicability year (IPAY) 2027 of the Drug Price Negotiation Program...
News
02 May 2024
On April 22, 2024, the Centers for Medicare & Medicaid Services (CMS) issued the Medicaid and Children's Health Insurance Program (CHIP) Managed Care Access, Finance, and Quality...
News
25 April 2024
The HIPAA Privacy Rule has been modified by the US Department of Health and Human Services (“HHS”) to increase privacy protections for reproductive health care information....
News
19 April 2024
On April 19, 2024, the Health Resources and Services Administration (HRSA) published a final rule (Final Rule) in the Federal Register adopting several changes to the current administrative ...
News
18 April 2024
While economic factors, including the high cost of capital, continue to keep our clients up at night, we also see signs of optimism in 2024. Against this fiscal backdrop, significant recent ...
News
12 April 2024
Life sciences and health care companies are heavily regulated under the rigorous standards of the U.S. Food and Drug Administration to ensure high levels of quality and patient safety....
News
11 April 2024
Our team is always thinking about how to foresee and conquer the most significant industry issues facing our clients. In 2020, we launched the podcast "Talking the Cure" where we cover...
